Hallux Valgus Pain Isn’t Only About Bone Deformity — MTP Joint Inflammation and Stem Cell Conditioned Media Injection as a Conservative Option2026.07.09
Many people understand hallux valgus (bunion) as a disease of bone deformity, but what actually makes daily walking painful is the inflammation occurring within the joint at the base of the big toe. The angle of deformity and the intensity of pain do not always correspond. Behind severe symptoms, we often find osteoarthritic changes and synovitis of the first metatarsophalangeal (MTP) joint. Recently, a hallux valgus injection using stem cell conditioned media has been considered as a conservative option that targets this inflammatory layer.
Key Points of This Article
・Hallux valgus pain is driven not only by bone deformity but also by synovitis and osteoarthritic changes in the first MTP joint.
・Conservative care (shoe modification, insoles, toe exercises) is the foundation, and a hallux valgus injection with stem cell conditioned media serves as a supplementary option for the inflammatory layer.
・Injection therapy does not correct bone deformity itself; severe deformity or joint destruction may require surgical intervention.
・Individual response varies, and objective outcome assessment combined with orthotics and exercise therapy is essential.
Why Hallux Valgus Pain Cannot Be Explained by the Angle Alone
Deformity Severity and Pain Do Not Always Match
Hallux valgus is the condition where the big toe deviates laterally and the base joint protrudes medially. Yet some people with a large hallux valgus (HV) angle report almost no pain, while others with mild-to-moderate deformity experience severe walking pain. The difference is not the bone itself but how much MTP joint inflammation, synovial swelling, capsular tension, and mechanical stress around the sesamoids contribute to the pain. Treatment cannot be decided by the imaging angle alone.
Synovitis and Osteoarthritic Change in the MTP Joint
During walking, the first MTP joint bears several times body weight repeatedly. When deformed, the joint surfaces contact unevenly, causing chronic cartilage wear and mechanical synovial irritation. The synovium continuously releases inflammatory cytokines such as IL-1β and TNF-α, which increase joint effusion and capsular swelling, amplifying pain. When a bursitis (bunion) develops medially, shoe-contact pain adds another layer. Understanding that osteoarthritic change and synovitis always underlie hallux valgus pain is the starting point of treatment design.
Limits of Conservative Care and the Rationale for Stem Cell Conditioned Media Injection
What Conservative Care Can and Cannot Reach
The foundation of treatment is conservative care: wide-fit shoes, arch-supporting insoles, toe abduction exercises, towel curls, and NSAIDs when needed. Yet chronic inflammation from advanced osteoarthritic change is not always adequately calmed by orthotics or exercise alone. Corticosteroid injection strongly suppresses inflammation but raises concerns about cartilage and tendon effects when repeated — a difficult long-term strategy for a small weight-bearing joint.
Conditioned Media Targets the Inflammatory and Reparative Environment
Stem cell conditioned media is a collective term for the secretome of mesenchymal stem cells cultured in vitro, including cytokines, growth factors, and exosomes. When delivered intra-articularly, anti-inflammatory cytokines are thought to modulate the synovitis and influence extracellular matrix metabolism, as suggested by basic research. Unlike steroids, negative effects on cartilage are less anticipated, which makes it a realistic option for the repeatedly loaded first MTP joint. That said, individual variation is large, and treatment must be designed with honest expectations about response.
What to Expect and What Not to Overexpect
Layers the Injection Can Target
Hallux valgus pain includes multiple layers: (1) inflammation associated with osteoarthritic change, (2) synovial swelling, and (3) chronic capsular and ligamentous stress. Stem cell conditioned media targets the inflammatory and tissue-repair environment among them. Under ultrasound guidance, precise intra-articular delivery to the first MTP joint has clinically been associated with reduced early loading pain and morning stiffness. Please also see our page on stem cell conditioned media joint injection for details.
Bone Deformity Cannot Be Corrected
On the other hand, conditioned media cannot correct the bone deformity itself. When the HV angle is large, when the big toe underrides the second toe, when sesamoid dislocation is present, or when joint destruction is advanced, pain relief from injection is often only temporary. Please also refer to guidelines by the Japanese Orthopaedic Association, and discuss the appropriateness of surgical options such as osteotomy with an orthopedic surgeon when indicated.
How Treatment Progresses and When Surgery Enters the Picture
When considering a hallux valgus injection with stem cell conditioned media, the premise is to continue conservative care — footwear guidance, insoles, and intrinsic-foot exercises — as the foundation. Injection is added when pain and functional decline interfere with daily life. Outcome assessment is performed over weeks to months, using pain scores, range of motion, and walking distance as objective indicators. When the response is poor or deformity progresses rapidly, switching to orthopedic reassessment is more appropriate than repeated injections. Combining orthotics and rehabilitation to maintain long-term function is the realistic goal.
Frequently Asked Questions
Q. Can a stem cell conditioned media injection cure hallux valgus deformity?
No, this treatment does not correct the bone deformity itself. It targets the inflammation within the first MTP joint and the associated pain and mobility limitation. In cases of severe deformity or advanced joint destruction, surgical options may need to be considered.
Q. How is efficacy assessed and over what time frame?
Pain, walking pain, and range of motion are evaluated over several weeks to months after injection. Rather than judging by a single dose, we follow the course and consider additional dosing or combined treatments. Individual response varies.
Q. Should I continue insoles and shoe guidance?
Yes. Conservative care is the foundation. Combining orthotics and exercise reduces joint load and helps sustain the effect of injection. Repeating injections without this foundation is not recommended.
Q. How does this differ from steroid injection?
Steroids strongly suppress inflammation but raise concerns about cartilage and tendon effects when repeated. Stem cell conditioned media aims at anti-inflammatory action and modulation of the tissue-repair environment, positioning it differently as an option.
Q. How should I think about the choice between injection and surgery?
The decision considers pain intensity, degree of deformity, impact on daily life, and response to conservative care. We recommend first obtaining an orthopedic evaluation to confirm whether conservative options remain reasonable or whether surgery is realistic.
──────────────
【監修】森脇 進 / Shin Moriwaki（監修医師）
日本美容外科学会(JSAS)会員 / American Academy of Aesthetic Medicine 会員
米国医師免許資格(ECFMG certificate)
──────────────
📍AVAN TOKYO 銀座 再生医療
AVAN TOKYO Ginza Regenerative Medicine
English / 中文 / Tiếng Việt supported
Inquiries welcomed via DM / LINE / Website / Phone.